Forskning
Udskriv Udskriv
Switch language
Rigshospitalet - en del af Københavns Universitetshospital
Udgivet

MEK/ERK/1/2 sensitive vascular changes coincide with retinal functional deficit, following transient ophthalmic artery occlusion

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

DOI

  1. Bruch's membrane allows unhindered passage of up to 2 μm latex beads in an in vivo porcine model

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  2. Distribution of CGRP and its receptor components CLR and RAMP1 in the rat retina

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  3. Non-invasive tryptophan fluorescence measurements as a novel method of grading cataract

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  4. Retinal pigment epithelial cells upregulate expression of complement factors after co-culture with activated T cells

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  5. Pharmacokinetics of intravitreal glial cell line-derived neurotrophic factor: experimental studies in pigs

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  1. Altered surface expression of P2Y11 receptor with narcolepsy-associated mutations

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  2. Exploration of purinergic receptors as potential anti-migraine targets using established pre-clinical migraine models

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  3. Does inflammation have a role in migraine?

    Publikation: Bidrag til tidsskriftReviewForskningpeer review

  4. The changing faces of migraine

    Publikation: Bidrag til tidsskriftLederForskningpeer review

Vis graf over relationer

Retinal ischemia remains a major cause of blindness in the world with few acute treatments available. Recent emphasis on retinal vasculature and the ophthalmic artery's vascular properties after ischemia has shown an increase in vasoconstrictive functionality, as previously observed in cerebral arteries following stroke. Specifically, endothelin-1 (ET-1) receptor-mediated vasoconstriction regulated by the MEK/ERK1/2 pathway. In this study, the ophthalmic artery of rats was occluded for 2 h with the middle cerebral artery occlusion model. MEK/ERK1/2 inhibitor U0126 was administered at 0, 6, and 24 h following reperfusion and the functional properties of the ophthalmic artery were evaluated at 48 h post reperfusion. Additionally, retinal function was evaluated at day 1, 4, and 7 after reperfusion. Occlusion of the ophthalmic artery led to a significant increase of endothelin-1 mediated vasoconstriction which can be attenuated by U0126 treatment, most evident at higher ET-1 concentrations of 10-7 M (Emax151.0 ± 22.0% of 60 mM K+), vs non-treated ischemic arteries Emax 212.1 ± 14.7% of 60 mM K+). Retinal function also deteriorated following ischemia and was improved with treatment with a-wave amplitudes of 725 ± 36 μV in control, 560 ± 21 μV in non-treated, and 668 ± 73 μV in U0126 treated at 2 log cd*s/m2 luminance in the acute stages (1 days post-ischemia). Full spontaneous retinal recovery was observed at day 7 regardless of treatment. In conclusion, this is the first study to show a beneficial in vivo effect of U0126 on vascular contractility following ischemia in the ophthalmic artery. Coupled with the knowledge obtained from cerebral vasculature, these results point towards a novel therapeutic approach following ischemia-related injuries to the eye.

OriginalsprogEngelsk
TidsskriftExperimental Eye Research
Vol/bind179
Sider (fra-til)142-149
Antal sider8
ISSN0014-4835
DOI
StatusUdgivet - 2019

ID: 55802422